University of North Carolina at Chapel Hill, J.D., high honors, 2014, Order of the Coif; North Carolina Law Review
George Mason University, B.S., high distinction, 1998
Sandra Wilburn assists clients in fund formations, private investment transactions and assorted intellectual property-related matters. She regularly works with fund managers to develop and execute fund offerings and advises institutional investors regarding their investments in private equity, venture capital, hedge funds and assorted other alternative investment funds. In her intellectual property and licensing practice, Sandra assists clients with software licensing, technology development and other intellectual property matters, and advises clients regarding domestic and international data privacy laws. She also provides general corporate assistance to a range of clients across industries and development stages.
Prior to joining Robinson Bradshaw, Sandra was an attorney at K&L Gates. Before entering the legal field, she worked as a sales executive, providing technology consultation to pharmaceutical and biotechnology companies in areas such as DNA sequencing, laboratory robotics and analytic software across the research and clinical development spectrum. Sandra is admitted to practice before the U.S. Patent and Trademark Office.
Honors & Awards
- The Best Lawyers in America, One to Watch, corporate, intellectual property, leveraged buyouts and private equity, 2022-23
- North Carolina Super Lawyers, Rising Star, securities and corporate finance, 2023
Negotiated and drafted transaction documents in connection with a secondary transaction involving 50 selling entities and approximately 400 interests in 125 domestic and foreign private equity funds on behalf of a global asset management firm.
Represents private equity sponsor in raising over $150 million of capital commitments for multiple real estate-focused funds.
Represents a pooled investment fund manager in connection with the formation of multiple funds with aggregate capital commitments over $300 million.
Represents a global private markets firm in a secondary market sale of approximately 140 fund interests.
Represents institutional investors in connection with various investments, both domestic and foreign, in private investment funds of all types.
Represents a large, regional health care system in the negotiation of numerous software licensing and consulting arrangements and other technology-related agreements.
Represents multiple companies in the defense, health care and technology industries in connection with their strategic venture capital investments in early-stage companies.
Assisted in due diligence review and analysis on behalf of an international public health care company for its $2 billion acquisition of a home dialysis equipment maker.
News & Events
- May 15, 2023
- Jan. 20, 2023
- Aug. 23, 2022
- Jan. 4, 2022
- Aug. 26, 2021
- Feb. 26, 2019
- Oct. 10, 2016
- April 28, 2021Robinson Bradshaw Publication
- Jan. 20, 2021Robinson Bradshaw Publication
- Oct. 22, 2020Robinson Bradshaw Publication
- Aug. 5, 2020Robinson Bradshaw Publication
- April 28, 2020Robinson Bradshaw Publication
- Jan. 21, 2020Robinson Bradshaw Publication
- Jan. 16, 2019Robinson Bradshaw Publication
- March 22, 2017American Health Lawyers Association
- North Carolina Bar Association
- Licensed to practice before the U.S. Patent and Trademark Office